Clinical Trial Update: Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15) [Phase 2]

View source ↗

Summary

Phase 2 pediatric trial EPIC-15 evaluating ivermectin in children under 15 kg has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Scabies

Drugs mentioned

• IVERMECTIN (Ivermectin)

Snippet

Sponsor: University of Oxford | Conditions: Scabies | Phase 2 | Status: COMPLETED